IFITM3 and Alzheimer disease: Due to this reduction, the levels of innate immunity protein interferon-induced transmembrane protein 3 (IFITM3), known for increasing Aβ production by binding and upregulating the activity of γ-secretase [17], were also reduced in STB-MP-treated AD cortical brain organoids (Figure 4B–D).